Xilio Therapeutics Inc.

0.91
0.00 (0.44%)
At close: Mar 03, 2025, 3:59 PM
0.86
-5.15%
After-hours: Mar 03, 2025, 04:37 PM EST

Xilio Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 44.7M 120.39M 198.05M 19.24M 48.84M
Short-Term Investments n/a n/a n/a n/a n/a
Long-Term Investments n/a 1.56M 1.55M 1.55M 194K
Other Long-Term Assets 1.6M 267K 1.95M 500K 1.55M
Receivables n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 3.42M 8.22M 8.93M 1.35M 2.26M
Total Current Assets 48.13M 124.5M 202.52M 20.59M 51.1M
Property-Plant & Equipment 11.2M 12.84M 13.6M 13.68M 9.87M
Goodwill & Intangibles n/a n/a -5.09M n/a n/a
Total Long-Term Assets 12.8M 14.67M 15.54M 15.73M 11.62M
Total Assets 60.93M 139.16M 218.06M 36.32M 62.72M
Account Payables 1.05M 3.13M 3.14M 5.44M 2.52M
Deferred Revenue n/a n/a 8.75M 13.73M n/a
Short-Term Debt 3.31M 7.58M 801K 2.9M n/a
Other Current Liabilities 11.59M 10.41M 8.83M 13.81M 2.69M
Total Current Liabilities 15.96M 21.12M 12.78M 22.16M 5.21M
Long-Term Debt 8.14M 12.35M 19.73M 18.32M 18.63M
Other Long-Term Liabilities 1.00 45K 118K 79.13M 68.41M
Total Long-Term Liabilities 8.14M 12.4M 19.85M 97.45M 87.04M
Total Liabilities 24.1M 33.52M 32.63M 119.6M 92.25M
Total Debt 11.46M 19.94M 20.54M 21.22M 18.63M
Common Stock 3K 3K 3K 1K n/a
Retained Earnings -325.51M -249.11M -160.89M -85.09M -29.87M
Comprehensive Income n/a n/a -218.06M -78M n/a
Shareholders Equity 36.83M 105.65M 185.43M -83.29M -29.52M
Total Investments 1.59M 1.56M 1.55M 1.55M 194K